Impax Laboratories (IPXL) settles a lawsuit with Sanofi (SNY) unit Genzyme over two kidney...

|About: Impax Laboratories, Inc. (IPXL)|By:, SA News Editor

Impax Laboratories (IPXL) settles a lawsuit with Sanofi (SNY) unit Genzyme over two kidney disease drugs, with the latter agreeing to grant Impax a license to sell generic versions of Renvela and Renagel by mid-March 2014 and mid-September 2014 respectively. Last month Impax settled with Pfizer over bladder control treatment Detrol LA. (PR)